{"id":"https://openalex.org/W3029344012","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.4506","title":"Donafenib versus sorafenib as first-line therapy in advanced hepatocellular carcinoma: An open-label, randomized, multicenter phase II/III trial.","display_name":"Donafenib versus sorafenib as first-line therapy in advanced hepatocellular carcinoma: An open-label, randomized, multicenter phase II/III trial.","publication_year":2020,"publication_date":"2020-05-20","ids":{"openalex":"https://openalex.org/W3029344012","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.4506","mag":"3029344012"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.15_suppl.4506","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.4506","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.4506","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067643729","display_name":"Feng Bi","orcid":"https://orcid.org/0000-0002-0527-5105","observed_orcids":["https://orcid.org/0000-0002-0527-5105","https://orcid.org/0009-0002-2759-1624","https://orcid.org/0000-0002-7815-9025"]},"institutions":[{"id":"https://openalex.org/I24185976","display_name":"Sichuan University","ror":"https://ror.org/011ashp19","country_code":"CN","type":"education","lineage":["https://openalex.org/I24185976"]},{"id":"https://openalex.org/I4210089761","display_name":"West China Hospital of Sichuan University","ror":"https://ror.org/007mrxy13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210089761"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Feng Bi","raw_affiliation_strings":["Department of Medical Oncology, West China Hospital, Sichuan University, Chengdu, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, West China Hospital, Sichuan University, Chengdu, China;","institution_ids":["https://openalex.org/I24185976","https://openalex.org/I4210089761"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043672686","display_name":"Shukui Qin","orcid":"https://orcid.org/0000-0003-2289-1521","observed_orcids":["https://orcid.org/0000-0003-2289-1521"]},"institutions":[{"id":"https://openalex.org/I4210118317","display_name":"81th Hospital of PLA","ror":"https://ror.org/02xxx6w64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210118317"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shukui Qin","raw_affiliation_strings":["PLA Cancer Center, Nanjing Bayi Hospital, Nanjing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PLA Cancer Center, Nanjing Bayi Hospital, Nanjing, China;","institution_ids":["https://openalex.org/I4210118317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073108755","display_name":"Shanzhi Gu","orcid":"https://orcid.org/0000-0001-6099-4543","observed_orcids":["https://orcid.org/0000-0001-6099-4543"]},"institutions":[{"id":"https://openalex.org/I4210115624","display_name":"Hunan Cancer Hospital","ror":"https://ror.org/025020z88","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210115624"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shanzhi Gu","raw_affiliation_strings":["Hunan Cancer Hospital, Changsha, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hunan Cancer Hospital, Changsha, China;","institution_ids":["https://openalex.org/I4210115624"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087661837","display_name":"Yuxian Bai","orcid":"https://orcid.org/0000-0002-5004-7523","observed_orcids":["https://orcid.org/0000-0002-5004-7523"]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuxian Bai","raw_affiliation_strings":["Harbin Medical University Cancer Hospital, Harbin, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harbin Medical University Cancer Hospital, Harbin, China;","institution_ids":["https://openalex.org/I4210103956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100755911","display_name":"Zhendong Chen","orcid":"https://orcid.org/0009-0009-1459-3234","observed_orcids":["https://orcid.org/0009-0009-1459-3234","https://orcid.org/0000-0001-7481-3985","https://orcid.org/0000-0002-5188-6804"]},"institutions":[{"id":"https://openalex.org/I4210149412","display_name":"Second Affiliated Hospital of Anhui Medical University","ror":"https://ror.org/047aw1y82","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210149412"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhendong Chen","raw_affiliation_strings":["The Second Hospital of Anhui Medical University, Hefei, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Second Hospital of Anhui Medical University, Hefei, China;","institution_ids":["https://openalex.org/I4210149412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041109198","display_name":"Zishu Wang","orcid":"https://orcid.org/0000-0002-1625-2195","observed_orcids":["https://orcid.org/0000-0002-1625-2195"]},"institutions":[{"id":"https://openalex.org/I4210150172","display_name":"First Affiliated Hospital of Bengbu Medical College","ror":"https://ror.org/04v043n92","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210150172"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zishu Wang","raw_affiliation_strings":["The First Affiliated Hospital of Bengbu Medical College, Bengbu, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The First Affiliated Hospital of Bengbu Medical College, Bengbu, China;","institution_ids":["https://openalex.org/I4210150172"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048541371","display_name":"Jieer Ying","orcid":"https://orcid.org/0000-0001-9452-1242","observed_orcids":["https://orcid.org/0000-0001-9452-1242"]},"institutions":[{"id":"https://openalex.org/I4210098734","display_name":"Zhejiang Cancer Hospital","ror":"https://ror.org/0144s0951","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098734"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jieer Ying","raw_affiliation_strings":["Zhejiang Cancer Hospital, Hangzhou, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhejiang Cancer Hospital, Hangzhou, China;","institution_ids":["https://openalex.org/I4210098734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064260340","display_name":"Yinying Lu","orcid":"https://orcid.org/0000-0002-0109-8340","observed_orcids":["https://orcid.org/0000-0002-0109-8340"]},"institutions":[{"id":"https://openalex.org/I2802939634","display_name":"Chinese PLA General Hospital","ror":"https://ror.org/04gw3ra78","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802939634"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yinying Lu","raw_affiliation_strings":["The Fifth Medical Center of PLA General Hospital, Beijing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Fifth Medical Center of PLA General Hospital, Beijing, China;","institution_ids":["https://openalex.org/I2802939634"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003930955","display_name":"Zhiqiang Meng","orcid":"https://orcid.org/0000-0003-3593-6098","observed_orcids":["https://orcid.org/0000-0003-3593-6098","https://orcid.org/0000-0001-7550-3129"]},"institutions":[{"id":"https://openalex.org/I4210093194","display_name":"Fudan University Shanghai Cancer Center","ror":"https://ror.org/00my25942","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093194"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhiqiang Meng","raw_affiliation_strings":["Fudan University Shanghai Cancer Center, Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fudan University Shanghai Cancer Center, Shanghai, China;","institution_ids":["https://openalex.org/I4210093194"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045553246","display_name":"Hongming Pan","orcid":"https://orcid.org/0000-0001-5034-3392","observed_orcids":["https://orcid.org/0000-0001-5034-3392","https://orcid.org/0009-0003-7751-6750"]},"institutions":[{"id":"https://openalex.org/I2802390878","display_name":"Sir Run Run Shaw Hospital","ror":"https://ror.org/00ka6rp58","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802390878"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hongming Pan","raw_affiliation_strings":["Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China;","institution_ids":["https://openalex.org/I2802390878","https://openalex.org/I76130692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115590300","display_name":"Ping Yang","orcid":"https://orcid.org/0009-0003-3987-7467","observed_orcids":["https://orcid.org/0009-0003-3987-7467","https://orcid.org/0000-0001-6923-9253","https://orcid.org/0009-0000-8512-7470"]},"institutions":[{"id":"https://openalex.org/I2802939634","display_name":"Chinese PLA General Hospital","ror":"https://ror.org/04gw3ra78","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802939634"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ping Yang","raw_affiliation_strings":["The Sixth Medical Center of PLA General Hospital, Beijing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Sixth Medical Center of PLA General Hospital, Beijing, China;","institution_ids":["https://openalex.org/I2802939634"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023128001","display_name":"Helong Zhang","orcid":"https://orcid.org/0000-0001-8430-6071","observed_orcids":["https://orcid.org/0000-0001-8430-6071"]},"institutions":[{"id":"https://openalex.org/I4210154136","display_name":"Tang Du Hospital","ror":"https://ror.org/04yvdan45","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210154136"]},{"id":"https://openalex.org/I9916479","display_name":"Air Force Medical University","ror":"https://ror.org/00ms48f15","country_code":"CN","type":"education","lineage":["https://openalex.org/I9916479"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Helong Zhang","raw_affiliation_strings":["Tangdu Hospital, Air Force Medical University, Xi\u2019an, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tangdu Hospital, Air Force Medical University, Xi\u2019an, China;","institution_ids":["https://openalex.org/I4210154136","https://openalex.org/I9916479"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100329878","display_name":"Xi Chen","orcid":"https://orcid.org/0000-0001-8691-1232","observed_orcids":["https://orcid.org/0000-0001-8691-1232"]},"institutions":[{"id":"https://openalex.org/I4210160531","display_name":"Chinese People's Liberation Army","ror":"https://ror.org/05tf9r976","country_code":"CN","type":"government","lineage":["https://openalex.org/I4210160531"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xi Chen","raw_affiliation_strings":["The 900th Hospital of PLA Joint Service Support Force, Fuzhou, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The 900th Hospital of PLA Joint Service Support Force, Fuzhou, China;","institution_ids":["https://openalex.org/I4210160531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101209267","display_name":"Aibing Xu","orcid":"https://orcid.org/0009-0000-7092-029X","observed_orcids":["https://orcid.org/0009-0000-7092-029X"]},"institutions":[{"id":"https://openalex.org/I4210105390","display_name":"Nantong Tumor Hospital","ror":"https://ror.org/01egmr022","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210105390"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Aibing Xu","raw_affiliation_strings":["Nantong Tumor Hospital, Nantong, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nantong Tumor Hospital, Nantong, China;","institution_ids":["https://openalex.org/I4210105390"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100735903","display_name":"Xiufeng Liu","orcid":"https://orcid.org/0000-0002-1599-2474","observed_orcids":["https://orcid.org/0000-0002-1599-2474"]},"institutions":[{"id":"https://openalex.org/I4210118317","display_name":"81th Hospital of PLA","ror":"https://ror.org/02xxx6w64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210118317"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiufeng Liu","raw_affiliation_strings":["PLA Cancer Center, Nanjing Bayi Hospital, Nanjing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PLA Cancer Center, Nanjing Bayi Hospital, Nanjing, China;","institution_ids":["https://openalex.org/I4210118317"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Qiu Meng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24185976","display_name":"Sichuan University","ror":"https://ror.org/011ashp19","country_code":"CN","type":"education","lineage":["https://openalex.org/I24185976"]},{"id":"https://openalex.org/I4210089761","display_name":"West China Hospital of Sichuan University","ror":"https://ror.org/007mrxy13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210089761"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qiu Meng","raw_affiliation_strings":["Department of Medical Oncology, West China Hospital, Sichuan University, Chengdu, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, West China Hospital, Sichuan University, Chengdu, China;","institution_ids":["https://openalex.org/I24185976","https://openalex.org/I4210089761"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001271717","display_name":"Liqing Wu","orcid":"https://orcid.org/0009-0007-4686-0961","observed_orcids":["https://orcid.org/0009-0007-4686-0961"]},"institutions":[{"id":"https://openalex.org/I4405267781","display_name":"Suzhou Zelgen Biopharmaceuticals Co., Ltd. (China)","ror":"https://ror.org/04b2whc36","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267781"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Liqing Wu","raw_affiliation_strings":["Suzhou Zelgen Biopharmaceuticals Co., Ltd., Suzhou, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Suzhou Zelgen Biopharmaceuticals Co., Ltd., Suzhou, China;","institution_ids":["https://openalex.org/I4405267781"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052987214","display_name":"Feng Chen","orcid":"https://orcid.org/0000-0003-4800-6762","observed_orcids":["https://orcid.org/0000-0003-4800-6762"]},"institutions":[{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Feng Chen","raw_affiliation_strings":["School of Public Health, Nanjing Medical University, Nanjing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Public Health, Nanjing Medical University, Nanjing, China;","institution_ids":["https://openalex.org/I83519826"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":18,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"15_suppl","first_page":"4506","last_page":"4506"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/donafenib","display_name":"donafenib","score":0.9800000190734863},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":1.0},{"id":"https://openalex.org/keywords/advanced-hepatocellular-carcinoma","display_name":"advanced hepatocellular carcinoma","score":0.9139999747276306},{"id":"https://openalex.org/keywords/multikinase-inhibitor","display_name":"multikinase inhibitor","score":0.8479999899864197},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.9829999804496765},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9300000071525574},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9649999737739563},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8579999804496765},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.859000027179718},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.3160000145435333},{"id":"https://openalex.org/keywords/unresectable-liver-cancer","display_name":"unresectable liver cancer","score":0.6100000143051147},{"id":"https://openalex.org/keywords/treatment-interruption","display_name":"treatment interruption","score":0.3050000071525574},{"id":"https://openalex.org/keywords/liver-reserve-function","display_name":"liver function reserve","score":0.33000001311302185},{"id":"https://openalex.org/keywords/chinese-patients","display_name":"Chinese patients","score":0.34200000762939453},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6729999780654907}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9249749779701233},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.9168375730514526},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7147201895713806},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6654387712478638},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6647881269454956},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.6459382176399231},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5297186374664307},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5200968980789185},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.49638015031814575},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.49312588572502136},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4415128529071808},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.418901652097702},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3573618531227112},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.19928684830665588}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.15_suppl.4506","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.4506","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.4506","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3175451049","https://openalex.org/W3192476850","https://openalex.org/W3202428687","https://openalex.org/W2889586005","https://openalex.org/W4379336131","https://openalex.org/W4379333002","https://openalex.org/W4400414008","https://openalex.org/W4320002136","https://openalex.org/W3088140463","https://openalex.org/W4400415250"],"abstract_inverted_index":{"4506":[0],"Background:":[1],"Sorafenib":[2],"is":[3,318],"still":[4],"the":[5,98,121],"standard":[6],"first-line":[7,322],"therapy":[8,56,323],"for":[9,324],"advanced":[10,325],"hepatocellular":[11],"carcinoma":[12],"(HCC).":[13],"Donafenib,":[14],"a":[15,23,45,139,319],"novel":[16],"multikinase":[17],"inhibitor,":[18],"showed":[19],"potential":[20],"benefits":[21],"in":[22,28,120,146,181,220,244],"previous":[24],"phase":[25,35],"Ib":[26],"study":[27],"HCC.":[29,326],"Methods:":[30],"In":[31],"this":[32],"open-label,":[33],"randomized":[34,65,113],"II/III":[36],"trial":[37,330],"(ZGDH3),":[38],"patients":[39,111,226,267],"with":[40,138,279,283,312],"unresectable":[41],"or":[42,73,82,214],"metastatic":[43],"HCC,":[44],"Child-Pugh":[46],"liver":[47],"function":[48],"score":[49],"\u2264":[50],"7,":[51],"and":[52,64,107,118,164,202,223,232,237,253,302,315],"no":[53,178],"prior":[54],"systemic":[55],"were":[57,112,128,177],"enrolled":[58],"from":[59],"37":[60],"sites":[61],"across":[62],"China":[63],"(1:1)":[66],"to":[67,240],"receive":[68],"oral":[69],"donafenib":[70,284],"(0.2":[71],"g)":[72,76],"sorafenib":[74,145,311],"(0.4":[75],"twice":[77],"daily":[78],"until":[79],"intolerable":[80],"toxicity":[81],"disease":[83,203],"progression.":[84],"The":[85],"primary":[86],"endpoint":[87],"was":[88,94,136],"overall":[89],"survival":[90,184],"(OS).":[91],"Efficacy":[92],"analysis":[93,100],"primarily":[95],"based":[96],"on":[97],"full":[99],"set":[101],"(FAS).":[102],"Results:":[103],"Between":[104],"March":[105],"2016":[106],"April":[108],"2018,":[109],"668":[110],"(donafenib,":[114],"334;":[115],"sorafenib,":[116],"334)":[117],"included":[119,285],"intention-to-treat":[122],"(ITT)":[123],"set,":[124],"of":[125,234,266],"whom":[126],"659":[127],"analysed":[129],"by":[130],"FAS":[131,148],"(328":[132],"vs":[133,151,168,187,197,207,247,256,273],"331).":[134],"Donafenib":[135,306,317],"associated":[137],"significantly":[140,307],"longer":[141],"median":[142,182],"OS":[143,309],"than":[144],"both":[147],"(12.1":[149],"months":[150,167,186],"10.3":[152],"months,":[153,170,189],"hazard":[154],"ratio":[155],"0.831,":[156],"95%":[157],"confidence":[158],"interval":[159],"0.699\u20130.988,":[160],"p":[161,173,190,199,209,228,250,259,276],"=":[162,174,191,200,210,229,251,260,277],"0.0363)":[163],"ITT":[165],"(12.0":[166],"10.1":[169],"0.839,":[171],"0.706\u20130.996,":[172],"0.0446).":[175],"There":[176],"significant":[179],"differences":[180],"progression-free":[183],"(3.7":[185],"3.6":[188],"0.2824),":[192],"objective":[193],"response":[194],"rate":[195,205],"(4.6%":[196],"2.7%,":[198],"0.2448),":[201],"control":[204],"(30.8%":[206],"28.7%,":[208],"0.5532).":[211],"Grade":[212],"3":[213],"worse":[215],"adverse":[216],"events":[217],"(AEs)":[218],"occurred":[219,243],"191":[221],"(57.4%)":[222],"224":[224],"(67.5%)":[225],"(":[227],"0.0082),":[230],"respectively,":[231],"AEs":[233,270,282],"special":[235],"interest":[236],"those":[238],"leading":[239],"treatment":[241],"interruption":[242],"287":[245],"(86.2%)":[246],"309":[248],"(93.1%,":[249],"0.0049)":[252],"101":[254],"(30.3%)":[255],"141":[257],"(42.5%,":[258],"0.0013).":[261],"A":[262],"numerically":[263],"lower":[264],"number":[265],"reported":[268],"serious":[269],"(55":[271],"[16.5%]":[272],"67":[274],"[20.2%],":[275],"0.2307)":[278],"donafenib.":[280],"Common":[281],"hand-foot":[286],"skin":[287],"reaction":[288],"(50.5%),":[289],"aspartate":[290],"aminotransferase":[291],"increased":[292,296],"(40.5%),":[293],"blood":[294],"bilirubin":[295],"(39.0%),":[297],"platelet":[298],"count":[299],"decreased":[300],"(37.8%),":[301],"diarrhea":[303],"(36.6%).":[304],"Conclusions:":[305],"improves":[308],"over":[310],"favourable":[313],"safety":[314],"tolerability.":[316],"promising":[320],"superior":[321],"Funding:":[327],"Zelgen.":[328],"Clinical":[329],"information:":[331],"NCT02645981":[332],".":[333]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":18},{"year":2020,"cited_by_count":7}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2020-06-05T00:00:00"}